Yoshida H - Search Results

1

Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation.

Nishihara S, Yamaoka T, Ishikawa F, Ohmori T, Ando K, Kusumoto S, Kishino Y, Manabe R, Hasebe Y, Sagara H, Yoshida H, Tsurutani J. Nishihara S, et al. Among authors: yoshida h. Cells. 2022 Jul 14;11(14):2201. doi: 10.3390/cells11142201. Cells. 2022. PMID: 35883645 Free PMC article.

2

[Primary appendiceal signet ring cell carcinoma:a case report].

Nakajima Y, Kajiwara A, Sakaki M, Otoyama Y, Nishihara S, Suzuki N, Usami T, Nakatani S, Wang T, Yoshida H. Nakajima Y, et al. Among authors: yoshida h. Nihon Shokakibyo Gakkai Zasshi. 2019;116(11):927-933. doi: 10.11405/nisshoshi.116.927. Nihon Shokakibyo Gakkai Zasshi. 2019. PMID: 31708505 Japanese.

3

Primary endoscopic bile duct stone removal for severe acute cholangitis: a retrospective study.

Ishii Y, Nakayama A, Nakatani K, Nishihara S, Oikawa S, Usami T, Noguchi T, Mitsui Y, Yoshida H. Ishii Y, et al. Among authors: yoshida h. Ther Adv Gastrointest Endosc. 2021 Sep 25;14:26317745211044009. doi: 10.1177/26317745211044009. eCollection 2021 Jan-Dec. Ther Adv Gastrointest Endosc. 2021. PMID: 34595474 Free PMC article.

4

Hemostasis using a covered self-expandable metal stent for pseudoaneurysm bleeding from the perihilar bile duct.

Ishii Y, Nakayama A, Kikuchi K, Nakatani K, Konda K, Mori D, Nishihara S, Oikawa S, Nomoto T, Usami T, Noguchi T, Mitsui Y, Yoshida H. Ishii Y, et al. Among authors: yoshida h. DEN Open. 2022 Jun 30;3(1):e150. doi: 10.1002/deo2.150. eCollection 2023 Apr. DEN Open. 2022. PMID: 35898842 Free PMC article.

5

Mechanisms of EGFR-TKI-Induced Apoptosis and Strategies Targeting Apoptosis in EGFR-Mutated Non-Small Cell Lung Cancer.

Nishihara S, Yamaoka T, Ishikawa F, Higuchi K, Hasebe Y, Manabe R, Kishino Y, Kusumoto S, Ando K, Kuroda Y, Ohmori T, Sagara H, Yoshida H, Tsurutani J. Nishihara S, et al. Among authors: yoshida h. Genes (Basel). 2022 Nov 22;13(12):2183. doi: 10.3390/genes13122183. Genes (Basel). 2022. PMID: 36553449 Free PMC article. Review.

6

Distinct molecular features of different macroscopic subtypes of colorectal neoplasms.

Konda K, Konishi K, Yamochi T, Ito YM, Nozawa H, Tojo M, Shinmura K, Kogo M, Katagiri A, Kubota Y, Muramoto T, Yano Y, Kobayashi Y, Kihara T, Tagawa T, Makino R, Takimoto M, Imawari M, Yoshida H. Konda K, et al. Among authors: yoshida h. PLoS One. 2014 Aug 5;9(8):e103822. doi: 10.1371/journal.pone.0103822. eCollection 2014. PLoS One. 2014. PMID: 25093594 Free PMC article.

7

Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.

Arai J, Goto K, Tanoue Y, Ito S, Muroyama R, Matsubara Y, Nakagawa R, Kaise Y, Lim LA, Yoshida H, Kato N. Arai J, et al. Among authors: yoshida h. Int J Cancer. 2018 Nov 15;143(10):2575-2583. doi: 10.1002/ijc.31615. Epub 2018 Sep 22. Int J Cancer. 2018. PMID: 29873070 Free article.

8

Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.

Arai J, Goto K, Otoyama Y, Nakajima Y, Sugiura I, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Nozawa H, Nakagawa R, Muroyama R, Kato N, Yoshida H. Arai J, et al. Among authors: yoshida h. Cancer Immunol Immunother. 2021 Jan;70(1):203-213. doi: 10.1007/s00262-020-02660-2. Epub 2020 Jul 18. Cancer Immunol Immunother. 2021. PMID: 32683508 Free PMC article.

9

Retinoids Decrease Soluble MICA Concentration by Inhibiting the Enzymatic Activity of ADAM9 and ADAM10.

Otoyama Y, Arai J, Goto K, Nozawa H, Nakagawa R, Muroyama R, Sugiura I, Nakajima Y, Kajiwara A, Tojo M, Ichikawa Y, Uozumi S, Shimozuma Y, Uchikoshi M, Sakaki M, Kato N, Yoshida H. Otoyama Y, et al. Among authors: yoshida h. Anticancer Res. 2021 May;41(5):2307-2320. doi: 10.21873/anticanres.15006. Anticancer Res. 2021. PMID: 33952456

10

Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer.

Arai J, Otoyama Y, Fujita KI, Goto K, Tojo M, Katagiri A, Nozawa H, Kubota Y, Takahashi T, Ishida H, Tsunoda T, Matsumoto N, Ogawa K, Nakagawa R, Muroyama R, Kato N, Yoshida H. Arai J, et al. Among authors: yoshida h. BMC Cancer. 2022 Apr 20;22(1):428. doi: 10.1186/s12885-022-09512-5. BMC Cancer. 2022. PMID: 35443621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,834 results

Search Page